Does LIPITOR Cause Interstitial lung disease? 5 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Interstitial lung disease have been filed in association with LIPITOR. This represents 0.1% of all adverse event reports for LIPITOR.
5
Reports of Interstitial lung disease with LIPITOR
0.1%
of all LIPITOR reports
1
Deaths
4
Hospitalizations
How Dangerous Is Interstitial lung disease From LIPITOR?
Of the 5 reports, 1 (20.0%) resulted in death, 4 (80.0%) required hospitalization, and 2 (40.0%) were considered life-threatening.
Is Interstitial lung disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LIPITOR. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does LIPITOR Cause?
Type 2 diabetes mellitus (2,783)
Drug hypersensitivity (233)
Myalgia (121)
Pain in extremity (82)
Neuropathy peripheral (79)
Muscle spasms (76)
Pain (58)
Death (55)
Muscular weakness (52)
Arthralgia (51)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which LIPITOR Alternatives Have Lower Interstitial lung disease Risk?
LIPITOR vs LIRAGLUTIDE
LIPITOR vs LISDEXAMFETAMINE
LIPITOR vs LISDEXAMFETAMINE DIMESYLATE
LIPITOR vs LISINOPRIL
LIPITOR vs LISOCABTAGENE MARALEUCEL